Rockwell Medical (RMTI) Raised to Hold at BidaskClub

BidaskClub upgraded shares of Rockwell Medical (NASDAQ:RMTI) from a sell rating to a hold rating in a research report report published on Saturday morning.

Separately, Zacks Investment Research lowered shares of Rockwell Medical from a hold rating to a sell rating in a report on Wednesday, November 15th.

Shares of Rockwell Medical (RMTI) opened at $5.95 on Friday. Rockwell Medical has a fifty-two week low of $5.06 and a fifty-two week high of $8.98. The company has a market cap of $307.98, a price-to-earnings ratio of -13.84 and a beta of 2.02.

Rockwell Medical (NASDAQ:RMTI) last released its earnings results on Wednesday, November 8th. The company reported ($0.10) EPS for the quarter, hitting analysts’ consensus estimates of ($0.10). Rockwell Medical had a negative net margin of 39.28% and a negative return on equity of 46.63%. The firm had revenue of $14.63 million during the quarter, compared to analyst estimates of $13.33 million. During the same quarter in the previous year, the business earned ($0.09) EPS. The business’s quarterly revenue was up 14.2% compared to the same quarter last year. equities research analysts predict that Rockwell Medical will post -0.44 earnings per share for the current year.

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. GSA Capital Partners LLP grew its holdings in Rockwell Medical by 216.8% during the 2nd quarter. GSA Capital Partners LLP now owns 76,566 shares of the company’s stock worth $607,000 after acquiring an additional 52,400 shares during the period. Northern Trust Corp grew its holdings in Rockwell Medical by 4.8% during the 2nd quarter. Northern Trust Corp now owns 618,045 shares of the company’s stock worth $4,901,000 after acquiring an additional 28,482 shares during the period. Athos Capital Ltd acquired a new stake in Rockwell Medical during the 3rd quarter worth $6,834,000. Vanguard Group Inc. grew its holdings in Rockwell Medical by 4.6% during the 2nd quarter. Vanguard Group Inc. now owns 2,080,843 shares of the company’s stock worth $16,501,000 after acquiring an additional 90,786 shares during the period. Finally, Voya Investment Management LLC grew its holdings in Rockwell Medical by 11.9% during the 2nd quarter. Voya Investment Management LLC now owns 27,232 shares of the company’s stock worth $216,000 after acquiring an additional 2,895 shares during the period. 21.26% of the stock is owned by hedge funds and other institutional investors.

ILLEGAL ACTIVITY WARNING: This story was originally posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this story on another publication, it was copied illegally and reposted in violation of United States and international copyright and trademark legislation. The legal version of this story can be accessed at

Rockwell Medical Company Profile

Rockwell Medical, Inc (Rockwell) is a biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with products and services for the treatment of iron deficiency, secondary hyperparathyroidism and hemodialysis. The Company operates through the hemodialysis market segment, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceutical, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process.

Receive News & Ratings for Rockwell Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rockwell Medical and related companies with's FREE daily email newsletter.

Leave a Reply